## 



## 

## 

## 

|||||Pages|
|---|---|---|---|---|
|Report ofthe Chair||||2-3|
|Report ofthe Trustees||||4-15|
|Independent<br>Auditor's|Report|||16-21|
|Statement of Financial|Activities|(including the Income and Expenditure|account)|22|
|Balance Sheet||||23-24|
|Statement ofCash Flows||||25|
|Notes to the Financial|Statements|||26-37|





## 

## 

## 



## 

## 

## 




## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 



## 

## 

## 

## 



## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

|Reference and|Reference and|administrative|administrative|details (continued)||||
|---|---|---|---|---|---|---|---|
|Charity Commissions|||registered|charity number|1137652|||
|OSCR registered||charity number|||SC044535|||
|Registered|address||||51St Olav's Court|||
||||||Lower Road|||
||||||London, SE162KB|||
|Independent|Auditors||||Harris &Co (Accountants)|Ltd||
||||||2 Pavilion Court, 600 Pavilion||Drive|
||||||Northampton,<br>NN4 75L|||
|Bankers|||||CAF Bank Limited|||
||||||25 Kings Hill Avenue, West Mailing,|||
||||||Kent, ME194JQ|||
|Investment|managers||||Church,<br>Charity and Local|Authority||
||||||Investment<br>Management|Ltd,||
||||||Senator House, 85 Queen|Victoria||
||||||Street, London, EC4V4ET|||
|HR law advisory||service|||Howarths<br>HR and Employment||Law Ltd|
||||||Newbury<br>Court, Brooke Street|||
||||||Cleckheaton,<br>West Yorkshire,||BD19 3RR|



## 



## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

|AR ENDED 31MARCH 2|022||||||
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total funds|Total funds|
|||Note|Income Fund|Income|2022|2021|
|||||Fund|||
|Income and endowments|from:||||||
|Donations<br>and legacies|||579,457|474,364|1,053,821|719,842|
|Activities for generating|funds||172,872||172,872|139,360|
|Investments|||535||535|1,318|
|Other||||||43,075|
|Total income and endowments|||752,864|474,364|1,227,228|903,595|
|Expenditure<br>on:|||||||
|Raising funds|||265,093||265 093|188482|
|Charitable<br>activities|||359,335|436,907|796,242|538,767|
|Total expenditure||8|624,428|436,907|1,061,335|727,249|
|Net gains/(losses)<br>on investments|||104,658||104,658|252,627|
|Net income/(expenditure)|||233,094|37,457|270,551|428,973|
|Transfers between funds|||||||
|Net movement<br>in funds|||233,094|37,457|270,551|428,973|
|Reconciliation<br>offunds:|||||||
|Total Funds at 31March|2021||1,863,691|244,710|2,108,401|1,679,428|
|Total funds at 31March|2022||2,096,785|282,167|2,378,952|2,108,401|





## 

## 

## 

## 

## 

|31MARCH|202|2||||||||
|---|---|---|---|---|---|---|---|---|---|
|||||||Unrestricted|Restricted|Total|Total|
||||||Note|Income|Income|funds|funds|
|||||||Fund|Fund|2022|2021|
|Fixed assets||||||||||
|Tangible assets|||||12|12,104||12,104|10,244|
|Investments|||||13|1,702,192|731,333|2,433,525|2,328,396|
|||||||1,714,296|731,333|2,445,629|2,338,640|
|Current assets||||||||||
|Stocks|||||14|8,505||8,505|7,570|
|Debtors|||||15|64,874||64,874|243,209|
|Cash at bank|and|in|hand||16|339,096||339,096|191,470|
|||||||412,475||412,475|442,249|
|Liabilities:||||||||||
|Creditors: Amounts|||falling due within one||17|(29,986)|(209,801)|(239,787)|(442,517)|
|year||||||||||
|Net current|assets/(liabilities)|||||382,489|(209,801)|172,688|(268)|
|Total assets|less|current||liabilities||2,096,785|521,532|2,618,317|2,338,372|
|Creditors: Amounts|||falling due after more||18||(239,365)|(239,365)|(229,971)|
|than one year||||||||||
|Net assets/(liabilities)||||||2,096,785|282,167|2,378,952|2,108,401|
|Charity Funds||||||||||
|Unrestricted|funds|||||1,991,656||1,991,656|1,609,851|
|Revaluation|reserve|||||105,129||105,129|253,840|
|Restricted<br>funds|||||23||282,167|282,167|244,710|
|Total charity|funds|||||2,096,785|282,167|2,378,952|2,108,401|





## 

## 

## 

## 



## 

## 

## 

|AR ENDED 31MARCH 20|22|||||
|---|---|---|---|---|---|
|||||Total funds|Total funds|
||||Note|2022|2021|
|Cash flow from operating|activities||19|154,051|(26,612)|
|Cash flow from investing|activities|||||
|Interest received||||535|1,318|
|Payments to acquire oftangible<br>fixed assets||||(6,489)|(3,777)|
|Receipts from sales oftangible<br>assets|||||44|
|Payments to acquire investments||||(471)|(301,213)|
|Receipts from sale of investments|||||300,000|
|Net cash flow from investing<br>activities||||(6,425)|(3,628)|
|Change<br>in cash and cash|equivalents|||147,626|(30,240)|
|Cash and cash equivalents|brought|forward||191,470|221,710|
|Cash and cash equivalents|carried|forward||339,096|191,470|
|Cash and cash equivalents|consist|of:||||
|Cash at bank and<br>in hand||||339,096|191,470|
|Short term deposits||||||
|Cash and cash equivalents|at 31March 2022|||339,096|191,470|





## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

|Income|from donations<br>and legacies|||||
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Total|
|||Income|Income|2022|2021|
|||Fund|Fund|||
|||E|E|f||
|Donations|and legacies|||||
|Donations|under the Gift Aid scheme|64,933||64,933|60,389|
|Legacy donations||135,408||135,408|55,261|
|Memoriam|donations|184,375|34,119|218,494|170,605|
|Other donations||194,741|440,245|634,986|433,587|
|||579,457|474,364|1,053,821|719,842|





## 

## 

## 

## 

|Income from activities for ge|nerating<br>funds||||
|---|---|---|---|---|
||Unrestricted|Restricted|Total|Total|
||income|Income|2022|2021|
||Fund|Fund|||
|||E|E|E|
|Event income|158,410||158,410|127,186|
|Merchandise|14,462||14,462|12,174|
||172,872||172,872|139,360|



## 

|||||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|---|---|---|
|||||||income|Income|2022|2021|
|||||||Fund|Fund|||
||||||||E|E|E|
|Interest|receivable|from|UK|deposit|account|535||535|1,318|
|||||||535||535|1,318|



||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|
||||Income|Income|2022|2021|
||||Fund|Fund|||
||||E|f|E||
|Job|retention|scheme||||43,075|
|||||||43,075|



## 

|Net inco|me/(|expenditu|re)<br>and n|et movements<br>in funds have|been stated after charging|:|
|---|---|---|---|---|---|---|
||||||Total|Total|
||||||2022|2021|
||||||E|E|
|Depreciation|of|tangible|fixed assets||4,629|3,488|
|(Profit)/loss|on|fair value|movement|ofinvestments|(104,658)|(252,627)|





## 

## 

## 

|Analysis ofreso|urces expended|||
|---|---|---|---|
|||Total|Total|
|||2022|2021|
|||E|E|
|Cost ofgenerating|funds|||
|Merchandise||4,218|3,822|
|Events and catering||5,907|1,674|
|Salaries||139,757|96,248|
|PR and Marketing||3,560|3,912|
|Support costs||111,651|82,826|
|||265,093|188,482|



|tricted<br>fun|ds was E nil (2021-f nil).|||||
|---|---|---|---|---|---|
|||Direct|Support|Total|Total|
|||activities|costs|2022|2021|
||||E|E|E|
|Charitable|activities|||||
|Research||290,072|17,764|307,836|119,846|
|Info and patient support||364,068|124,338|488,406|418,921|
|||654,140|142,102|796,242|538,767|



## 

|alysis ofsup|port costs||||||
|---|---|---|---|---|---|---|
||||Cost of|Research|Info and|Total|
||||generating||patient||
||||funds||supper"t||
|||||E|||
|Bookkeeping|and administration|fees|1,229|196|1,369|2,794|
|Rent|||15,253|2,427|16,985|34,665|
|Office costs|||66,644|10,603|74,218|151,465|
|Sundry|||351|56|391|798|
|Governance|costs (see note 9)||28,174|4,482|31,375|64,031|
||||111,651|17,764|124,338|253,753|





## 

## 

## 

||||Total|Total|
|---|---|---|---|---|
||||2022|2021|
||||f|f|
|Auditor's|remuneration||4,203|3,888|
|Accountancy||fees|2,788|2,932|
|Professional||fees|31,251|25,385|
|Salaries|||25,739|27,480|
|Trustees'|meetings||51|10|
||||64,032|59,695|



## 

|||||Grants to|Direct|Support|Total|
|---|---|---|---|---|---|---|---|
|||||Institutions|costs|costs||
|||||f|f|E|f|
|Dr|Yee|Yeh|Goh|246,560|||246,560|
|||||246,560|||246,560|



## 

|e average number of pe|rsons employed<br>by the charity during|the year was:||
|---|---|---|---|
|||Total|Total|
|||2022|2021|
|Office staff||10||
|Specialist nurses||||
|Advocacy Officer/Social|Welfare Specialist|||
|||15|13|





## 

## 

## 

|. Staff costs (continued)|||
|---|---|---|
||Total|Total|
||2022|2021|
||E|E|
|Gross wages|482,177|410,979|
|Social security|42,317|34,480|
|Pension costs|24,041|18,321|
||548,535|463,780|



|12.Tangible|fixed assets|Office|Patient|Total|
|---|---|---|---|---|
|||equipment|Aids||
|||E|||
|Cost or valuation|||||
|At April 2021||22,765|57,577|80,342|
|Additions||6,489||6,489|
|Disposals|||||
|At 31March|2022|29,254|57,577|86,831|
|Depreciation|||||
|At April 2021||16,366|53,732|70,098|
|Charge for the year||2,919|1,710|4,629|
|Elimination|on disposal||||
|At 31March|2022|19,285|55,442|74,727|
|Net Book Value|||||
|At 31March|2022|9,969|2,135|12,104|
|At 31March|2021|6,399|3,845|10,244|





## 

## 

## 

|AR ENDED 31MARCH|AR ENDED 31MARCH|20|22|||
|---|---|---|---|---|---|
|13.Investments||||Total||
|||||2022||
|Cost or valuation||||||
|At 1April 2021||||2,328,396||
|Additions||||471||
|Disposals||||||
|Revaluation||||104,658||
|At 31March|2022|||2,433,525||
|Impairment||||||
|At 1April 2021and 31||March 2022||||
|Carrying amount||||||
|At 31March|2022|||2,433,525||
|At 31March|2021|||2,328,396||
||||||Market|
|||||Cost|Value|
|||||31March|31March|
|||||2022|2022|
|The Trustees'|investments||were made up as|E|f|
|follows:||||||
|CCLA||||1,986,652|2,433,525|
|||||1,986,652|2,433,525|
|||||31March|31March|
|||||2022|2021|
|Investments|at fair value||comprise:|E|E|
|Equities||||1,114,575|1,009,918|
|Cash with investment||portfolio||1,318,950|1,318,478|
|||||2,433,525|2,328,396|





## 

## 

## 

## 

|14.Stock|||
|---|---|---|
||2022|2021|
|Finished goods: Merchandise|8,505|7,570|
|15.Debtors|||
||2022|2021|
||E|E|
|Trade debtors|||
|Other debtors|22,345|44,993|
|Accrued income|42,529|198,216|
||64,874|243,209|



## 

|.Cash at bank|||||||
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Total|
||||income|income|funds|funds|
||||funds|funds|2022|2021|
|||||E|E|E|
|Cash committed|for|research grant funding|||||
|Other cash|||339,096||339,096|191,470|
||||339,096||339,096|191,470|
|.Creditors: amounts||falling due within one year|||||
||||||2022|2021|
||||||E|E|
|Accrual for Research||grants|||209,801|421,998|
|Other taxation|and|social security|||10,722|10,159|
|Other creditors|||||19,264|10,360|
||||||239,787|442,517|





## 

|2022|2021|
|---|---|
|E|E|
|239,365|229,971|



|.<br>Reconciliation<br>o|fne|t move|ment<br>in funds to net cash flo|w from operating<br>activities||
|---|---|---|---|---|---|
|||||Total|Total|
|||||funds|funds|
|||||2022|2021|
|Movement<br>in net funds||||270,551|428,973|
|Depreciation<br>oftangible||fixed|assets|4,629|3,488|
|Interest receivable||||(535)|(1,318)|
|(Gains)/losses<br>on investments||||(104,658)|(252,627)|
|Decrease/(Increase)|in|stocks||(935)|658|
|Decrease/(Increase)|in|debtors||178,335|(45,858)|
|Increase/(Decrease)|in|creditors||(193,336)|(159,928)|
|Net cash flow from|operating||activities|154,051|(26,612)|



## 

|at 31 <br>lows:|Marc|h 2022 the total minimum<br>lease payme|nts<br>under non-cancellable<br>operating<br>le|ases was a|
|---|---|---|---|---|
||||Total|Total|
||||funds|funds|
||||2022|2021|
|Within|one|year|2,404|2,404|
|Within|one|to five years|5,320|7,724|
||||7,724|10,128|





## 

|||||Research|Nurse|Regional|Other|Total|Total|
|---|---|---|---|---|---|---|---|---|---|
||||||specialists|Core||2022|2021|
|||||6|E|E||||
|Brought forward||funds||244,710||||244,710|305,952|
|Income arising|in|the year||284,017|98,885|26,076|65,386|474,364|205,819|
|Expenses paid|during the year|||(246,560)|(98,885)|(26,076)|(65,386)|(436,907)|(267,061)|
|Carried forward|funds|||282,167||||282,167|244,710|
|.Analysis offunds||||||||||
||||||At 1April|Incoming|Resources|Gains|At 31|
||||||2021|resources|expended|and|March|
|||||||||losses|2022|
|||||||E|E|||
|Analysis ofmovements|||in funds|||||||
|Unrestricted<br>fund|||||1,863,691|752,864|(624,428)|104,658|2,096,785|
|Restricted fund|||||244,710|474,364|(436,907)||282,167|



## 



## 

## 

## 

## 

|||Fixed|Net|Non-|Total|
|---|---|---|---|---|---|
|||assets|current|current||
||||assets|creditors||
|||||E|E|
|Unrestricted|fund|1,714,296|382,489||2,096,785|
|Restricted fund||731333|(209,801)|(239,365)|282,167|
|||2,445,629|172,688|(239,365)|2,378,952|



## 

|tially<br>reco|gnised at transaction<br>value and subsequ|ently<br>measured<br>at their amortised<br>cost.||
|---|---|---|---|
|Financial|assets|2022|2021|
|Trade debtors||||
|Other debtors||22,345|44,993|
|||22,345|44,993|
|Financial|liabilities|2022|2021|
|||E|E|
|Research|grants|449,167|651,969|
|Other creditors||29,986|20,519|
|||479,153|672,488|



|ir transaction<br>value<br>and subsequently<br>measure<br>e closing quoted market price:|d<br>at their fair value as at the balance she|et date using|
|---|---|---|
|Financial assets|2022|2021|
||E|E|
|Investments|2,433,525|2,328,396|



